首页|期刊导航|临床与实验病理学杂志|伴管状成分的乳腺浸润性小叶癌11例临床病理分析

伴管状成分的乳腺浸润性小叶癌11例临床病理分析OA

Clinicopathological features and immunohistochemical analysis of 11 cases of breast invasive lobular carcinoma with tubular components

中文摘要英文摘要

目的 探讨伴管状成分的乳腺浸润性小叶癌(invasive lobular carcinoma,ILC)的临床病理特征及免疫表型.方法 收集11例伴管状成分ILC的临床资料,并采用免疫组织化学(immunohistochemistry,IHC)检测ER、PR、HER2、Ki67、E-cadherin、p120、β-catenin、CK5/6、p63在癌组织中的表达,并复习相关文献,分析其与临床病理特征的关系.结果 患者平均年龄47.3岁(35~66岁);多位于左侧(8/11)、内上象限(5/11);肿瘤最大径平均29.4 mm(19.0~70.0 mm);易出现淋巴结转移(6/11).镜下见小而一致的肿瘤细胞排列成单行线性/条索状结构,并混有多少不等的管状结构.管状结构与单行线性/条索状结构混杂存在,在纤维性间质及周围脂肪组织中浸润性生长.其中10例伴小叶原位癌成分(10/11).免疫表型:ER、PR均阳性(11/11,100%);HER2 1例阳性,9例阴性,IHC1例HER2 2+未行FISH检测;Ki67增殖指数为10%~40%;CK5/6、p63均阴性.管状结构中肿瘤细胞E-cadherin阴性(0/11),p120胞膜阳性(7/11),β-catenin胞膜阳性(4/4);单行线性/条索状结构中肿瘤细胞E-cadherin阴性(0/11),p120胞质阳性(11/11),β-catenin胞膜阴性(0/4).结论 伴管状成分的ILC临床少见,肿瘤中管状成分IHC缺乏E-cadherin膜阳性,但多数保留了p120和β-catenin的膜阳性,需与小管癌、小管小叶癌和浸润性导管及小叶混合型癌鉴别.

Objective To investigate the clinicopathological features and immunophenotypic characteristics of in-vasive lobular carcinoma(ILC)of the breast with tubular components.Methods The clinicopathological data of 11 cases of ILC with tubular components were retrospectively analyzed.Immunohistochemical staining was used to detect the expression of ER,PR,HER2,Ki67,E-cadherin,p120,β-catenin,CK5/6,and p63 in the cancer tissues,re-view relevant literature and analyze its relationship with clinical pathological characteristics.Results The mean age of the patients was 47.3 years(ranging from 35 to 66 years);most of the tumors were located in the left side(8/11)and the upper inner quadrant(5/11);the mean maximum diameter of the tumors was 29.4 mm(ranging from 19.0 to 70.0 mm);lymph node metastasis was common(6/11).Microscopically,small and uniform tumor cells were ar-ranged in single-file linear/cord-like structures,mixed with varying amounts of tubular structures.The tubular struc-tures and single-file linear/cord-like structures were intermingled,showed invasive growth in the fibrous stroma and surrounding adipose tissue.Among them,10 cases were accompanied by lobular carcinoma in situ components(10/11).Immunohistochemistry showed that ER and PR were both positive(11/11,100%);HER2 was positive in 1 case,negative in 9 cases,and 1 case showed IHC 2+without FISH detection;the Ki67 proliferation index ranged from 10%to 40%;no expression of CK5/6 or p63 was observed in any case.In the tubular structures,tumor cells were negative for E-cadherin(0/11),showed membranous positivity for p120(7/11),and exhibited membranous posi-tivity for β-catenin(4/4);in the single-file linear/cord-like structures,tumor cells were negative for E-cadherin(0/11),showed cytoplasmic positivity for p120(11/11),and were negative for membranous β-catenin(0/4).Conclu-sion ILC with tubular components is rare in clinical practice,immunohistochemically,the tubular components lack membranous E-cadherin expression but mostly retain membranous expression of p120 and β-catenin.It should be dif-ferentiated from tubular carcinoma,tubulolobular carcinoma,and mixed invasive ductal and lobular carcinoma.

刘宇琼;黄会粉;任华艳;张敏;李晨飞;李惠翔

郑州大学第一附属医院病理科,郑州 450052郑州大学第一附属医院病理科,郑州 450052郑州大学第一附属医院病理科,郑州 450052郑州大学第一附属医院病理科,郑州 450052郑州大学第一附属医院病理科,郑州 450052郑州大学第一附属医院病理科,郑州 450052

医药卫生

乳腺肿瘤浸润性小叶癌免疫组织化学

breast neoplasmsinvasive lobular carcinomasimmunohistochemistry

《临床与实验病理学杂志》 2026 (2)

157-163,7

10.13315/j.cnki.cjcep.2026.02.003

评论